These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4896410)

  • 21. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Palagi L; D'Elia M; Lanzara P; Criscione SM
    Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
    [No Abstract]   [Full Text] [Related]  

  • 22. [Double blind study with clomidine and reserpine in ambulant therapy of hypertension].
    Dorscheid HO; Ehinger U; Förster W; Hempel J; Kondziella W; Schulz G; Schulz J; Sziegoleit W; Wolf R
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1017-20. PubMed ID: 4557762
    [No Abstract]   [Full Text] [Related]  

  • 23. Clonidine (Catapres): a new antihypertensive agent.
    Khan A; Camel G; Perry HM
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term clinical study and serial determination of urinary catecholamines using the new antihypertensive agent ST-155].
    Villalpando J; Skromme D; Chávez B; Serrano P
    Arch Inst Cardiol Mex; 1968; 38(6):841-50. PubMed ID: 5711376
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 26. [Debrisoquine sulfate, a new antihypertensive agent].
    Dieu Y
    Brux Med; 1970 Mar; 50(3):195-201. PubMed ID: 5446621
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
    Kotzaurek R; Schmidt P; Widhalm F
    Wien Klin Wochenschr; 1970 Nov; 82(45):805-9. PubMed ID: 5479019
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic examination and studies on renal function with a new antihypertensive agent (St 155)].
    Frank H; von Loewenich-Lagois K
    Dtsch Med Wochenschr; 1966 Sep; 91(38):1680-6. PubMed ID: 5917870
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of arterial hypertension with ST-155].
    Fonnesu C; Solinas F
    Clin Ter; 1970 Sep; 54(5):455-9. PubMed ID: 4949933
    [No Abstract]   [Full Text] [Related]  

  • 30. Guanoxan (compound 1003) in the treatment of hypertension.
    Ozen MA; Kadiglu A
    Curr Ther Res Clin Exp; 1965 Sep; 7(9):548-57. PubMed ID: 4953855
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience with Catapresan in the therapy of hypertension].
    Michel D
    Dtsch Med Wochenschr; 1968 Jul; 93(28):1375. PubMed ID: 5657231
    [No Abstract]   [Full Text] [Related]  

  • 32. [Contribution to the clinical trial of a new antihypertensive agent].
    Capuano G; Santoro C
    Rass Int Clin Ter; 1969 May; 49(10):615-20. PubMed ID: 5784808
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical studies on the mechanism of action of 2-(2,6-dichlorphenylamino)-2-imidazolinehydrochloric acid (Catapresan)].
    Scheja HW; Strum A
    Verh Dtsch Ges Inn Med; 1968; 74():559-62. PubMed ID: 5714381
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
    Ferreira EB; Eichemberg R; Berlitz MF
    Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evolution of the electrocardiogram of the hypertensive under hypotensive treatment].
    Miori R; Frezza M
    Folia Cardiol; 1965; 24(4):180-92. PubMed ID: 5897900
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical results obtained with a new hypotensive agent (2156 TH)].
    Bansillon M; Traeger J
    J Med Lyon; 1967 Jul; 48(124):1129-38. PubMed ID: 5619049
    [No Abstract]   [Full Text] [Related]  

  • 38. [A new hypotensive agent with central action].
    Fritel D
    Therapeutique; 1970 Nov; 46(9):893-5. PubMed ID: 5486137
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
    Corsini G; Di Filippo A; Cioffi A
    Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
    [No Abstract]   [Full Text] [Related]  

  • 40. [A new drug in the medical treatment of arterial hypertension: cyclazenin].
    Mameli P; Maioli M; Fanzecu P
    Rass Int Clin Ter; 1970 Apr; 50(8):457-64. PubMed ID: 4394494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.